Iingozi ezininzi zeentsholongwane zokuphefumla ebusika
Amanyathelo okunciphisa ukusasazeka kwe-SARS-CoV-2 nawo abe luncedo ekunciphiseni ukusasazeka kwezinye iintsholongwane zokuphefumla ezihlala zikhona. Njengoko amazwe amaninzi enciphisa ukusetyenziswa kwala manyathelo, i-SARS-CoV-2 iya kujikeleza nezinye iintsholongwane zokuphefumla, nto leyo eyandisa amathuba okusuleleka kunye nazo.
Iingcali ziqikelela ukuba kunokubakho ubhubhane wentsholongwane kathathu kulo busika ngenxa yokudibana kweencopho zonyaka ze-influenza (Flu) kunye ne-respiratory syndrome virus (RSV) kunye nobhubhane wentsholongwane ye-SARS-CoV-2. Inani lamatyala e-Flu kunye ne-RSV kulo nyaka sele liphezulu kunelo lexesha elifanayo kwiminyaka edlulileyo. Iindidi ezintsha ze-BA.4 kunye ne-BA.5 ze-SARS-CoV-2 virus ziye zayenza mandundu le ntsholongwane kwakhona.
Kwi-"World Flu Day 2022 Symposium" ngoNovemba 1, 2022, uZhong Nanshan, ingcali yezemfundo kwi-Chinese Academy of Engineering, uhlalutye ngokupheleleyo imeko yomkhuhlane ekhaya nakwamanye amazwe, waza wenza uphando lwamva nje kunye nokugweba imeko yangoku."Ihlabathi lisajongene nomngcipheko wezifo ezibangelwa yintsholongwane ye-SARS-CoV-2 kunye nobhubhane womkhuhlane." Ucacisile, "Ingakumbi kule busika, kusafuneka kuqiniswe uphando ngemiba yesayensi yokuthintela nokulawula umkhuhlane."Ngokwezibalo ze-US CDC, inani labantu abatyelela izibhedlele ngenxa yezifo zokuphefumla eMelika linyuke kakhulu ngenxa yokudibana kwe-influenza kunye nosulelo olutsha lwentliziyo.
Ukwanda kokubhaqwa kwe-RSV kunye nokutyelela amasebe angxamisekileyo anxulumene ne-RSV kunye nokulaliswa esibhedlele kwiindawo ezininzi zase-US, apho ezinye iindawo zisondela kumanqanaba aphezulu onyaka. Okwangoku, inani lamatyala osulelo lwe-RSV e-US lifikelele kwincopho ephezulu kwiminyaka engama-25, nto leyo ebangele ukuba izibhedlele zabantwana zixinene, kwaye ezinye izikolo zivaliwe.
Ubhubhane womkhuhlane uqhambuke eOstreliya ngo-Epreli kulo nyaka kwaye waqhubeka phantse iinyanga ezi-4. Ukusukela nge-25 kaSeptemba, bekukho amatyala omkhuhlane aqinisekisiweyo elebhu angama-224,565, nto leyo ebangele ukufa okunxulumene nawo okungama-305. Ngokwahlukileyo koko, phantsi kwamanyathelo okuthintela ubhubhane wentsholongwane ye-SARS-CoV-2, kuya kubakho amatyala omkhuhlane amalunga nama-21,000 eOstreliya ngo-2020 kwaye angaphantsi kwe-1,000 ngo-2021.
Ingxelo yeveki yama-35 yeZiko leNtsholongwane laseTshayina ngo-2022 ibonisa ukuba inani lamatyala omkhuhlane kumaphondo asemantla liphezulu kunenqanaba lexesha elifanayo ngo-2019-2021 kangangeeveki ezi-4 ezilandelelanayo, kwaye imeko yexesha elizayo iya kuba mandundu ngakumbi. Ukusukela phakathi kuJuni, inani lamatyala afana nomkhuhlane abikiweyo eGuangzhou linyuke ngama-10.38 amaxesha xa kuthelekiswa nonyaka ophelileyo.
Iziphumo zophando olwenziwe kumazwe ali-11 olukhutshwe yiThe Lancet Global Health ngo-Okthobha zibonise ukuba ukuchaphazeleka kwabantu abakhoyo ngoku kwi-influenza kunyuke nge-60% xa kuthelekiswa nangaphambi kobhubhane. Zikwaxele kwangaphambili ukuba incopho yexesha lomkhuhlane ka-2022 iya kunyuka nge-1-5, kwaye ubungakanani bobhubhane buya kunyuka nge-1-4.
Abantu abadala abangama-212,466 abanosulelo lwe-SARS-CoV-2 abangeniswe esibhedlele. Uvavanyo losulelo oluhambelana nentsholongwane yokuphefumla lurekhodwe kwizigulana ezingama-6,965 ezine-SARS-CoV-2. Usulelo oluhambelana nentsholongwane lufunyenwe kwizigulana ezingama-583 (8·4%): izigulana ezingama-227 zazineentsholongwane zomkhuhlane, izigulana ezingama-220 zazineentsholongwane zokuphefumla ezihambelana nentsholongwane, kwaye izigulana ezili-136 zazineentsholongwane ze-adenovirus.
Usulelo oluhlangeneyo neentsholongwane zomkhuhlane lunxulunyaniswa nokwanda kwamathuba okufumana umoya ongenisayo ngomatshini xa kuthelekiswa nosulelo lwe-SARS-CoV-2 mono-infection. Usulelo oluhlangeneyo lwe-SARS-CoV-2 neentsholongwane zomkhuhlane kunye nee-adenovirus nganye nganye inxulunyaniswa kakhulu nokwanda kwamathuba okufa. I-OR yomoya ongenisayo ngomatshini kwisifo somkhuhlane yayiyi-4.14 (95% CI 2.00-8.49, p=0.0001). I-OR yokufa esibhedlele kwizigulane ezine-influenza kunye ne-influenza yayiyi-2.35 (95% CI 1.07-5.12, p=0.031). I-OR yokufa esibhedlele kwizigulane ezine-adenovirus kunye ne-influenza yayiyi-1.6 (95% CI 1.03-2.44, p=0.033).
Iziphumo zolu phononongo zisixelela ngokucacileyo ukuba ukosulelwa ngaxeshanye yintsholongwane ye-SARS-CoV-2 kunye nentsholongwane yomkhuhlane yimeko eyingozi kakhulu.
Ngaphambi kokuqhambuka kwe-SARS-CoV-2, iimpawu zeentsholongwane zokuphefumla ezahlukeneyo zazifana kakhulu, kodwa iindlela zonyango zahlukile. Ukuba izigulana azixhomekekanga kuvavanyo oluninzi, unyango lweentsholongwane zokuphefumla luya kuba nzima ngakumbi, kwaye luya kuchithwa lula izixhobo zesibhedlele ngexesha leziganeko eziphezulu. Ke ngoko, uvavanyo oluninzi oludibeneyo ludlala indima ebalulekileyo ekuxilongweni kwezonyango, kwaye oogqirha bayakwazi ukunika uxilongo olwahlukileyo lweentsholongwane kwizigulana ezineempawu zokuphefumla ngesampuli enye ye-swab.
Isisombululo sokuFumana aMalungu amaninzi kunye noVavanyo oluNcinci lwe-SARS-CoV-2
I-Macro & Micro-Test inamaqonga obuchwephesha afana ne-fluorescent quantitative PCR, i-isothermal amplification, i-immunization, kunye ne-molecular POCT, kwaye ibonelela ngeemveliso ezahlukeneyo zokufumanisa amalunga okuphefumla e-SARS-CoV-2. Zonke iimveliso zifumene isiqinisekiso se-EU CE, kunye nokusebenza kakuhle kwemveliso kunye namava amahle omsebenzisi.
1. Ikhithi ye-RT-PCR ye-fluorescent yexesha langempela yokufumanisa iintlobo ezintandathu zezifo zokuphefumla
Ulawulo lwangaphakathi: Jonga ngokupheleleyo inkqubo yovavanyo ukuqinisekisa umgangatho wezilingo.
Ukusebenza kakuhle okuphezulu: I-PCR ye-Multiplex real-time ifumanisa iithagethi ezahlukeneyo ze-SARS-CoV-2, iFlu A, iFlu B, iAdenovirus, iMycoplasma pneumoniae, kunye neRespiratory syncytial virus.
Uvakalelo oluphezulu: Iikopi ezingama-300/mL ze-SARS-CoV-2, iikopi ezingama-500/mL zentsholongwane ye-influenza A, iikopi ezingama-500/mL zentsholongwane ye-influenza B, iikopi ezingama-500/mL zentsholongwane ye-respiratory syncytial, iikopi ezingama-500/mL ze-mycoplasma pneumoniae, kunye neekopi ezingama-500/mL ze-adenovirus.
2. I-SARS-CoV-2/Influenza A /Influenza B Nucleic Acid Combined Detection Kit (i-Fluorescence PCR)
Ulawulo lwangaphakathi: Jonga ngokupheleleyo inkqubo yovavanyo ukuqinisekisa umgangatho wezilingo.
Ukusebenza kakuhle okuphezulu: I-PCR ye-Multiplex real-time ifumanisa iithagethi ezahlukeneyo ze-SARS-CoV-2, iFlu A kunye neFlu B.
Uvakalelo oluphezulu: Iikopi ezingama-300/mL ze-SARS-CoV-2,500Iikopi/mL ze-lFV A kunye neekopi ezingama-500/mL ze-lFV B.
3. I-SARS-CoV-2, i-Influenza A kunye ne-Influenza B Antigen Detection Kit (Immunochromatography)
Kulula ukuyisebenzisa
Ubushushu begumbi Ukuthuthwa kunye nokugcinwa kwi-4-30°℃
Uvakalelo oluphezulu kunye nokucaciswa
| Igama lemveliso | Inkcazo |
| Ikhithi ye-RT-PCR ye-fluorescent yexesha langempela yokufumanisa iintlobo ezintandathu zezifo zokuphefumla | Uvavanyo oluyi-20/ikhithi,Iimvavanyo ezingama-48/ikhithi,Uvavanyo oluyi-50/ikhithi |
| Ikhithi yokuFumanisa i-SARS-CoV-2/Influenza A/Influenza B Nucleic Acid Combined Detection Kit (Fluorescence PCR) | Iimvavanyo ezingama-48/ikhithi,Uvavanyo oluyi-50/ikhithi |
| I-SARS-CoV-2, i-Influenza A kunye ne-Influenza B Antigen Detection Kit (Immunochromatography) | Uvavanyo/ikhithi e-1,Uvavanyo oluyi-20/ikhithi |
Ixesha lokuthumela: Disemba-09-2022